What Researchers Did
Researchers conducted a prospective, randomized clinical trial comparing two hyperbaric oxygen treatment protocols for adult patients with accidental carbon monoxide poisoning.
What They Found
Among 30 randomized patients, the average carboxyhemoglobin level was 24.8% and delay to treatment averaged 313 minutes, with no significant differences between the two treatment groups. Immediately after hyperbaric treatment, six patients (4 in the 2.4 atm abs group and 2 in the 3.0 atm abs group) showed abnormal neurocognitive test results.
What This Means for Canadian Patients
Canadian patients experiencing carbon monoxide poisoning may benefit from hyperbaric oxygen therapy, but this pilot study suggests the optimal treatment protocol requires further investigation. More research is needed to establish which specific hyperbaric oxygen parameters yield the best long-term outcomes for patients.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A significant limitation of this pilot study is its small sample size of 30 patients, which limits the generalizability of the findings.